PineBridge GEM II G.P., L.P. - 20 Nov 2024 Form 4 Insider Report for IBEX Ltd (IBEX)

Role
10%+ Owner
Signature
/s/ John Leone - for PineBridge GEM II G.P., L.P., By: PineBridge GEM II G.P., Co, its general partner, By: John Leone, Vice President
Issuer symbol
IBEX
Transactions as of
20 Nov 2024
Transactions value $
-$2,969,222
Form type
4
Filing time
22 Nov 2024, 16:16:05
Previous filing
10 Oct 2024
Next filing
04 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBEX Common Shares Sale -$1.58M -78.7K -4.58% $20.12 1.64M 20 Nov 2024 See Footnotes F1, F2, F3
transaction IBEX Common Shares Sale -$1.39M -69.3K -4.22% $20.00 1.57M 21 Nov 2024 See Footnotes F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.991 to $20.91, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 This is a joint filing by PineBridge Global Emerging Markets Partners II, L.P., a Cayman Islands limited partnership ("GEM II"), PineBridge GEM II G.P., L.P., a Cayman Islands limited partnership ("GEM II GP"), John Leone, Kevin Clowe and Pierre Mellinger. The reported shares are held directly by GEM II. GEM II GP is the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II. Mr. Leone, Mr. Clowe and Mr. Mellinger serve on the three-member investment committee of GEM II GP, which manages the investment activities of GEM II.
F3 GEM II GP, Mr. Leone, Mr. Clowe and Mr. Mellinger disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of the securities for purposes of Section 16 or any other purpose.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.97 to $20.04, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.